---
title: "CCGB: Some fundraising projects have been postponed"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/245264546.md"
description: "CCGB announced that some fundraising projects have been postponed. The company's board of directors and supervisory board approved the postponement proposal, which involves natural plant comprehensive extraction, nutritional medicinal comprehensive extraction, and land development projects in Zambia. The new completion dates are June 30, 2027, April 30, 2027, and December 31, 2026, respectively. The reasons for the postponement include changes in the global economic environment, slow market expansion, and optimization of production processes. The company promises to use the raised funds legally and effectively, and this postponement will not have a significant adverse impact on normal operations"
datetime: "2025-06-19T10:53:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/245264546.md)
  - [en](https://longbridge.com/en/news/245264546.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/245264546.md)
---

# CCGB: Some fundraising projects have been postponed

CCGB announced that the 17th meeting of the fifth board of directors and the 16th meeting of the fifth supervisory board reviewed and approved the proposal on the extension of certain fundraising investment projects, agreeing to extend the time for the "Integrated Natural Plant Comprehensive Extraction Project," "Nutritional Medicinal Comprehensive Extraction Project," and "Zambia Land Development and Supporting Infrastructure Construction Project" to reach the predetermined usable status. The expected completion dates after the extension are June 30, 2027, April 30, 2027, and December 31, 2026, respectively. The reasons for the extension include changes in the global economic environment, slow market development, and continuous optimization of production processes. The company will strictly comply with relevant regulations, make scientific decisions, strengthen supervision, and ensure the legal and effective use of raised funds. This extension will not have a significant adverse impact on the company's normal operations

### Related Stocks

- [300138.CN](https://longbridge.com/en/quote/300138.CN.md)

## Related News & Research

- [Lytix Biopharma Advances Ruxotemitide Program as Q1 2026 Results Underscore Oncology Focus](https://longbridge.com/en/news/287162474.md)
- [15:30 ETTravis Manion Foundation to Honor 10,000 Military Heroes on Memorial Day Weekend Through "The Honor Project"](https://longbridge.com/en/news/287109444.md)
- [PRECIOUS-Gold falls to 1-1/2-month low on higher US yields, firm dollar](https://longbridge.com/en/news/287016248.md)
- [PRECIOUS-Gold eases as higher yields, firm dollar offset US-Iran peace hopes](https://longbridge.com/en/news/286996403.md)
- [PRECIOUS-Treasury yields, dollar weigh on gold amid inflation concerns](https://longbridge.com/en/news/286929968.md)